2026/01/15 by Shuichi Suetani, Frances Dark, Susanna Every‐Palmer +11
Medicine · Psychology · #Family Caregiving in Mental Illness #Mental Health Treatment and Access #Schizophrenia research and treatment
paper · doi:10.1177/00048674251406058
crossref issued 2026/01/15 · crossref published 2026/01/15 · crossref published-online 2026/01/15 · openalex publication_date 2026/01/15 · crossref created 2026/01/16 · openalex created_date 2026/01/17 · crossref published-print 2026/04/01 · openalex updated_date 2026/07/25 · crossref deposited 2026/07/29 · crossref indexed 2026/07/29
OBJECTIVE: The current Guidelines aim to provide evidence-based management recommendations for treatment of people living with schizophrenia in Australia and Aotearoa New Zealand. METHODS: (ANZJP) commissioned a panel of experts to establish these Guidelines. The existing literature was reviewed to address key health questions. The certainty of evidence was evaluated using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach, and the strength of the recommendation was determined by the panel. RESULTS: The ANZJP GRADE Guidelines examined the current evidence base for a range of areas relevant to treatment for people with schizophrenia including: initial physical health assessment; pharmacological treatment; psychological and psychosocial interventions; family, whānau and carers; psychiatric comorbidities; physical health and lifestyle interventions; and special populations. CONCLUSIONS: It is hoped that the current Guidelines provide useful recommendations in important aspects of care for people living with schizophrenia and their family, whānau and carers in Australia and Aotearoa New Zealand, both at the individual and systemic levels.